MeSH term
Frequency | Condition_Probility | Animals | 7 | 0.0 |
Humans | 13 | 0.0 |
Lysophospholipids/*pharmacology | 3 | 8.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
*Receptors, G-Protein-Coupled | 10 | 3.0 |
Receptors, Lysophosphatidic Acid | 11 | 26.0 |
Receptors, Lysophospholipid | 2 | 5.0 |
Female | 7 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Male | 3 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Rats | 3 | 0.0 |
Receptors, Cell Surface/*biosynthesis/genetics | 2 | 8.0 |
Blotting, Northern | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Ovarian Neoplasms/*metabolism | 2 | 3.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Calcium/metabolism | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Receptors, Cell Surface/chemistry/genetics/*metabolism | 2 | 8.0 |
Spodoptera | 2 | 0.0 |
Base Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Lysophospholipids/*metabolism | 2 | 13.0 |
Organ Specificity | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Lysophospholipids/pharmacology | 2 | 4.0 |